KLF15 and diabetes mellitus: We demonstrated that the effect of metformin on BCAA uptake is clinically significant, as in a large cohort of genotyped DM patients, metformin treatment attenuates the LVH risk genotype of KLF15, a transcriptional ‘master regulator’ of BCAA catabolism.